Park H H - OmicsDI

Show results for

Unknown (31671)
Transcriptomics (567)
Proteomics (397)
Genomics (109)
Metabolomics (76)
Models (16)
Genomic (7)
Other (2)
Multiomics (2)

Organisms

Homo sapiens (325)
Mus musculus (128)
Drosophila melanogaster (54)
Arabidopsis thaliana (25)
Rattus norvegicus (19)
Oryza sativa (10)
Bos taurus (8)
Streptomyces venezuelae (6)
Escherichia coli str. K-12 substr. MG1655 (6)
Escherichia coli (5)
Caenorhabditis elegans (5)
Gallus gallus (4)
Geobacter sulfurreducens PCA (3)
Macaca mulatta (3)
Schizosaccharomyces pombe (3)
Oryza sativa Japonica Group (3)
Candida albicans (3)
Mammalia (2)
Sphyracephala beccarii (2)
Salmonella enterica subsp. enterica serovar Typhimurium str. UK-1 (2)
Aplysia californica (2)
Nitrosomonas europaea (2)
Lepidium sativum (2)
Cricetulus griseus (2)
Sus scrofa (2)
Danio rerio (2)
Rodentia (1)
Murinae (1)
cellular organisms (1)
Rattus (1)

Organisms

Homo sapiens (10)
Mus musculus (5)
Belgica antarctica (1)
Hibiscus mutabilis (1)
Halodule wrightii (1)
Dromaius novaehollandiae (1)
Hordeum vulgare (1)
gut metagenome (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (605)
pride (359)
MetaboLights (73)
EGA (45)
ENA (32)
MassIVE (20)
BioModels (16)
dbGaP (7)
jPOST (5)
GNPS (3)
iProX (3)
GPMDB (2)
PanoramaPublic (2)
geo (1)
PeptideAtlas (1)

Tissue

Cell culture (69)
Epithelial cell (37)
Brain (21)
Permanent cell line cell (18)
Blood plasma (14)
Macrophage (8)
Stem cell (8)
Heart (7)
Kidney (7)
Liver (7)
Embryo (6)
Blood (5)
Blood serum (5)
Fibroblast (5)
HeLa cell (5)
Skin (5)
B cell (4)
Cell suspension culture (4)
Colon (4)
Hepatocyte (4)
Monocyte (4)
Oral epithelium (4)
Primary cell (4)
T cell (4)
Whole body (4)
Blood cell (3)
Early embryonic cell (3)
Embryonic stem cell (3)
Keratinocyte (3)
Leaf (3)

Disease

Disease free (15)
Breast cancer (13)
Colon cancer (7)
Alzheimer's disease (6)
Cervix carcinoma (6)
Malignant neoplasm of ovary (5)
Acute leukemia (4)
Cardiovascular system disease (4)
Type 2 diabetes mellitus (4)
Huntington Disease (3)
Parkinson's disease (3)
Prostate adenocarcinoma (3)
Normal (2)
Not Available (2)
Bladder transitional cell carcinoma (2)
Colorectal cancer (2)
Craniopharyngioma (2)
Gray platelet syndrome (2)
Hepatocellular carcinoma (2)
Lung adenocarcinoma (2)
Lymphoma (2)
Pancreatic cancer (2)
Prostate cancer (2)
Hepatocellular carcinoma-non tumorous region (1)
ARR7ox-4-11 (1)
Bronchioloalveolar carcinoma of lung (1)
Breast carcinoma (invasive ductal) (1)
Neurologically healthy control (1)
Locally advanced rectal cancer (1)
N/a (1)

Technology Type

Mass Spectrometry (359)
Shotgun proteomics (187)
Bottom-up proteomics (72)
Mass spectrometry (56)
Data-dependent acquisition (43)
Affinity purification coupled with mass spectrometry proteomics (35)
Gel-based experiment (23)
SWATH MS (12)
NMR spectroscopy (9)
Top-down proteomics (9)
Mass spectrometry assay (8)
Chemical cross-linking coupled with mass spectrometry proteomics (7)
Data-independent acquisition (7)
SRM/MRM (6)
DiaPASEF (3)
HDMSE (3)
NMR spectroscopy assay (2)
Affinity proteomics (2)
Illumina HiSeq 2000, HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
Illumina OncoArray (1)
ILLUMINA, Illumina HiSeq 2500, HiSeq X Ten (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Illumina HiSeq 2000, Affymetrics_SNP_6.0-, Illumina Genome Analyzer IIx (1)
Affymetrix 6.0 (1)
Illumina MiSeq (1)
Mass spectrometry imaging (1)
Olink affinity proteomics (1)

Instrument Platform

Illumina HiSeq 2000 (8)
Q Exactive (8)
Illumina HiSeq 2500 (5)
Illumina NovaSeq 6000 (4)
Illumina HiSeq 4000 (4)
LTQ Orbitrap Elite (4)
LTQ Orbitrap Velos (3)
Orbitrap Fusion (3)
LTQ Orbitrap (3)
Illumina Genome Analyzer (2)
Illumina Genome Analyzer II (2)
Illumina NovaSeq X (2)
Illumina MiSeq (2)
NextSeq 500 (2)
Xevo G2 Q-Tof (2)
Instrument (2)
Impact (2)
NextSeq 500, 75 bp single end lane (1)
Pacbio Revio (1)
Sequel II (1)
GenePix 4200A (1)
Sequel (1)
Affymetrix GeneChip(R) HT Scanner (1)
Affymetrix GeneChip Scanner 3000 7G (1)
Axon- GenePix4000B (1)
MinION (1)
Illumina HiSeq 1500 (1)
NextSeq 550 (1)
Illumina HiSeq 3000 (1)
Q Exactive HF (1)

Publication Date

2011 (99)
2015 (92)
2013 (84)
2014 (77)
2010 (75)
2012 (67)
2026 (65)
2025 (63)
2024 (62)
2023 (52)
2022 (50)
2021 (48)
2020 (39)
2016 (38)
2018 (34)
2008 (33)
2017 (31)
2019 (30)
2009 (24)
2007 (10)
2005 (6)
2004 (4)
2006 (3)

UNIPROT ID/AC

Q61501 (1)
P13405 (1)
P97377 (1)
Q61457 (1)
Q9JKW8 (1)
P25322 (1)

CHEBI ID

CHEBI:15891 (25)
CHEBI:15428 (25)
CHEBI:17992 (24)
CHEBI:16704 (23)
CHEBI:30769 (22)
CHEBI:17568 (21)
CHEBI:16335 (21)
CHEBI:17596 (21)
CHEBI:15741 (20)
CHEBI:30915 (20)
CHEBI:17895 (20)
CHEBI:17295 (20)
CHEBI:16708 (19)
CHEBI:17754 (19)
CHEBI:6650 (19)
CHEBI:16015 (19)
CHEBI:16467 (16)
CHEBI:16643 (15)
CHEBI:15729 (14)
CHEBI:17148 (14)
CHEBI:16610 (11)
CHEBI:50211 (3)
CHEBI:22204 (1)
CHEBI:52217 (1)
CHEBI:15625 (1)
CHEBI:17312 (1)
CHEBI:15746 (1)
CHEBI:15346 (1)
CHEBI:15414 (1)
CHEBI:15351 (1)

Metabolite Name

Glucose (11)
Sucrose (11)
Inosine (10)
Phenylalanine (10)
Glycine (10)
Taurine (10)
L-Leucine (10)
L-Phenylalanine (10)
Glutamine (9)
Alanine (9)
Valine (9)
L-Alanine (9)
Uracil (9)
Glycerol (9)
Uracil (9)
Uridine (9)
L-Tyrosine (9)
Beta-Alanine (8)
Glycine (8)
Uridine (8)
Tryptophan (8)
Taurine (8)
Proline (8)
Guanosine (8)
Arginine (8)
Threonine (8)
Adenosine (8)
Isoleucine (8)
Glycerol (8)
Ornithine (8)

First Public Date

2023 (7)
2014 (5)
2026 (4)
2024 (4)
2025 (3)
2017 (2)
2013 (2)
2022 (1)
2021 (1)
2020 (1)
2019 (1)
2016 (1)

Modelling Approach

Ordinary differential equation model (11)
Constraint-based model (4)
Differential equation model (1)

Lab affiliation

Proteomics core facility, Biomedical Research Institute, Seoul National University Hospital (13)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (4)
Institute of Bioinformatics , International Technology Park, Bangalore, India (4)
University of Maryland, College Park (4)
Biological Chemistry and Molecular Pharmacology, Harvard Medical School Cancer Biology, Dana-Farber Cancer Institute (2)
Center for Genomic Integrity, Institute for Basic Science, Ulsan, Korea (2)
Center for Natural Product Systems Biology, Korea Institute of Science and Technology (2)
Chemical and Biological Integrative Research center, Korea Institute of Science and Technology (2)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (2)
Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea (2)
Department of Chemistry, Korea University (2)
Department of Plant Science and Technology, Chung-Ang University, Anseong, Republic of Korea (2)
Departments of Biomedical Sciences, Seoul National University, Seoul, Korea (2)
Epithelial Systems Biology Laboratory Systems Biology Center Division of Intramural Research National Heart, Lung and Blood Institute Building 10, Room 6N307 Bethesda, Maryland 20895-1603 (2)
Institute of Bioinformatics 7th floor, Discoverer building, International Tech Park, Bangalore 560 066 (2)
Korea Basic Science Institute (2)
Korea Institute of Science and Technology (2)
Kyungpook national university (2)
Ottawa Hospital Research Institute (2)
Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB) (2)
Ping Xu, Ph.D. Secretary General of CNHUPO Professor, Director Department of Genomics and Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing) Beijing Institute of Lifeomics， 38 Life Science Park Road, Beijing 102206, P.R. China. Tel: 0086-10-61777113, Fax: 0086-10-61777060 (2)
Prometabio Research Institute, prometabio co., ltd. (2)
Proteomics and Metabolomics Core Facility, Biomedical Research Institute, Seoul National University Hospital (2)
Proteomics core facility, Seoul National University Hospital (2)
Seoul National University (2)
Yonsei Proteome Research Center (2)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA (1)
1F, Bldg A, No.18 Science Park Road, Life Science Park, Changping District, Beijing 102206, P. R. China (1)
APAF, Macquarie University (1)
Adicet Bio Inc, Menlo Park, California, United States (1)

IsPrivate

False (16)

Model Flag

Non Kinetic (5)

Modification

4x(15)N labeled L-arginine (2)
1x(15)N labeled L-valine (1)
2x(15)N labeled L-lysine (1)
4 (1)

Study type

Transcription profiling by array (355)
RNA-seq of coding RNA (67)
ChIP-chip by tiling array (44)
ChIP-seq (27)
Comparative genomic hybridization by array (23)
Transcription profiling by tiling array (12)
RNA-seq of non coding RNA (12)
Unknown experiment type (10)
Methylation profiling by array (8)
Proteomic profiling by array (7)
High-throughput sequencing (5)
ChIP-chip by array (5)
RNA-seq of coding RNA from single cells (5)
Transcription profiling by RT-PCR (4)
Other (4)
Methylation profiling by high throughput sequencing (4)
Genotyping by array (3)
Transcription profiling by MPSS (1)
Baseline (1)
Plant - High-throughput sequencing (1)
Human - One-color microarray (1)
Bisulfite-seq (1)
RIP-seq (1)
MicroRNA profiling by array (1)
DNA-seq (1)
Genotyping by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2025 (3533)
2022 (3473)
2023 (3257)
2021 (3192)
2024 (3011)
2020 (2581)
2019 (2098)
2018 (1764)
2017 (1547)
2016 (1436)
2015 (1241)
2014 (1017)
2013 (741)
2012 (656)
2011 (629)
2026 (524)
2010 (485)
2009 (313)
2008 (248)
2007 (153)
2006 (104)
2005 (79)
2004 (59)
2003 (31)
2001 (29)
2002 (28)
2000 (18)
1999 (16)
1998 (8)
1997 (5)

Previous page
1 / 3285
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 3285
Next page

Sort by:

Relevance

Page size

Sex differences modulate the serum metabolome profiles in Parkinson’s disease patients harbouring pathogenic mutations in GBA1, LRRK2, TMEM175, PARK2, PINK1, and PARK7 genes

Background: Sex and genetic background have an impact on Parkinson’s disease (PD) insurgence, but the comprehension of how these factors affect the circulating profile of PD patients is still an aim of study.

Objectives: In this study we aimed to investigate whether genetic background and ...

2026-06-26 | MTBLS12753 | MetaboLights

C-H/C-C Functionalization Approach to N-Fused Heterocycles from Saturated Azacycles.

Not available

S-EPMC7773224 | biostudies-literature

Mechanism of Iminium Salt-Catalyzed C(sp³)-H Amination: Factors Controlling Hydride Transfer versus H-Atom Abstraction.

Not available

S-EPMC8188841 | biostudies-literature

Rational Development of Remote C-H Functionalization of Biphenyl: Experimental and Computational Studies.

Not available

S-EPMC7064431 | biostudies-literature

Heterolytic bond activation at gold: evidence for gold(iii) H-B, H-Si complexes, H-H and H-C cleavage.